11:08 AM EDT, 04/23/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were sharply higher late Wednesday morning, climbing 1.85% to 1,377.63 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firm BioNTech (BNTX) and accommodations booking company trivago (TRVG), which advanced 14% and 11% respectively. They were followed by Evaxion Biotech (EVAX) and biopharmaceutical firm Genfit (GNFT), which climbed 10% and 9.8% respectively.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and consumer goods company Unilever (UL), which fell 2.9% and 2.2% respectively. They were followed by petroleum refiner Equinor (EQNR) and telecommunications company Ericsson (ERIC), which were down 1.5% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and software firm Endava (DAVA), which rose 13% and 9.8% respectively. They were followed by cruise line operator Carnival (CUK) and biopharmaceutical company NuCana (NCNA), which increased 6.5% and 6% respectively.

The decliners from the UK and Ireland were led by utilities company National Grid (NGG) and biopharmaceutical company Akari Therapeutics (AKTX), which lost 3.6% and 2.9% respectively. They were followed by telecommunications operator Vodafone Group (VOD) and biopharmaceutical company Amarin (AMRN), which dropped 2.4% and 2.3% respectively.

http://www.mtnewswires.com
Copyright © 2025 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.